Attributes | Values |
---|
rdf:type
| |
description
| - artículu científicu espublizáu en 2010 (ast)
- 2010 թվականի նոյեմբերին հրատարակված գիտական հոդված (hy)
- наукова стаття, опублікована в листопаді 2010 (uk)
- 2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած (hyw)
- مقالة علمية (نشرت في نوفمبر 2010) (ar)
- wetenschappelijk artikel (gepubliceerd op 2010/11/01) (nl)
- scientific article (publication date: November 2010) (en)
- im November 2010 veröffentlichter wissenschaftlicher Artikel (de)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
cites work
| |
cites work
| |
author name string
| |
OpenCitations bibliographic resource ID
| |
OpenCitations bibliographic resource ID
| |
author name string
| - Fernando Rivera
- Kelly S Oliner
- Michael Wolf
- James Cassidy
- Paul Ruff
- Ronald Burkes
- Jean-Luc Canon
- Yves Humblet
- Jennifer Gansert
- Ilona Kocákova
|
OpenCitations bibliographic resource ID
| |
rdfs:label
| - Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (en)
- Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (ast)
|
skos:prefLabel
| - Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (en)
- Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (ast)
|
name
| - Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (en)
- Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (ast)
|
author
| |
author
| |
title
| |
title
| - Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
is about
of | |
is cites work
of | |